 Connection
Lindsey Dayer to Humans
This is a "connection" page, showing publications Lindsey Dayer has written about Humans.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.357 |
|
|
|
-
Dayer LE, Wagner R, King D, Lakkad M, Wilson LA, Montgomery C, Painter JT. Impact of Hydroxyurea Starting Dose on Pain Outcomes in Patients with Sickle Cell Disease. J Pain Palliat Care Pharmacother. 2022 Dec; 36(4):223-227.
Score: 0.036
-
Dayer LE, Breckling MN, Kling BS, Lakkad M, McDade ER, Painter JT. Association of the "CDC Guideline for Prescribing Opioids for Chronic Pain" With Emergency Department Opioid Prescribing. J Emerg Med. 2019 11; 57(5):597-602.
Score: 0.029
-
Dayer LE, McDade ER, Harrington S. Pharmacist-Delivered Patient Care in an Interdisciplinary Team-Based Institutional Palliative Care Clinic, 2012 to 2018. J Palliat Care. 2021 Jul; 36(3):188-193.
Score: 0.029
-
Dayer LE, Painter JT, McCain K, King J, Cullen J, Foster HR. A recent history of opioid use in the US: Three decades of change. Subst Use Misuse. 2019; 54(2):331-339.
Score: 0.027
-
Heldenbrand S, Martin BC, Gubbins PO, Hadden K, Renna C, Shilling R, Dayer L. Assessment of medication adherence app features, functionality, and health literacy level and the creation of a searchable Web-based adherence app resource for health care professionals and patients. J Am Pharm Assoc (2003). 2016 May-Jun; 56(3):293-302.
Score: 0.023
-
Dayer L, Dunn E, Pace A, Flowers S. Pharmacists' perceived knowledge of and confidence in dispensing oral antineoplastic agents. J Am Pharm Assoc (2003). 2016 Mar-Apr; 56(2):141-4.e2.
Score: 0.022
-
Dayer L, Harrington S, Martin B. Adherence to Adjuvant Neuropathic Pain Medications in a Palliative Care Clinic. J Palliat Med. 2016 05; 19(5):538-41.
Score: 0.022
-
Dayer LE, Hutchins LF, Johnson JT. Treatment of metastatic melanoma with pazopanib: A report of five patient cases. J Oncol Pharm Pract. 2015 Jun; 21(3):224-31.
Score: 0.020
-
Dayer L, Heldenbrand S, Anderson P, Gubbins PO, Martin BC. Smartphone medication adherence apps: potential benefits to patients and providers: response to Aungst. J Am Pharm Assoc (2003). 2013 Jul-Aug; 53(4):345.
Score: 0.019
-
Dayer L, Heldenbrand S, Anderson P, Gubbins PO, Martin BC. Smartphone medication adherence apps: potential benefits to patients and providers. J Am Pharm Assoc (2003). 2013 Mar-Apr; 53(2):172-81.
Score: 0.018
-
Acharya M, Hayes CJ, Li C, Painter JT, Dayer L, Martin BC. Opioid therapy trajectories of patients with chronic non-cancer pain over 1 year of follow-up after initiation of short-acting opioid formulations. Pain Med. 2024 Mar 01; 25(3):173-186.
Score: 0.010
-
Lakkad M, Martin B, Li C, Harrington S, Dayer L, Painter JT. Factors Associated With Guideline-Concordant Pharmacological Treatment for Neuropathic Pain Among Breast Cancer Survivors. Clin Breast Cancer. 2023 08; 23(6):598-619.
Score: 0.009
-
Choi AN, Dayer LE, Stafford RA, Dunn EB, Li C. Prior Pharmacy Work Experience as a Predictor of Clinical and Didactic Performance for Admissions Committees. Am J Pharm Educ. 2023 05; 87(5):100053.
Score: 0.009
-
Acharya M, Hayes CJ, Li C, Painter JT, Dayer L, Martin BC. Comparative Study of Opioid Initiation With Tramadol, Short-acting Hydrocodone, or Short-acting Oxycodone on Opioid-related Adverse Outcomes Among Chronic Noncancer Pain Patients. Clin J Pain. 2023 03 01; 39(3):107-118.
Score: 0.009
-
Lakkad M, Martin B, Li C, Harrington S, Dayer L, Painter JT. The use of gabapentinoids and opioids and risk of developing opioid-induced respiratory depression among older breast cancer survivors with neuropathic pain. J Cancer Surviv. 2024 Jun; 18(3):917-927.
Score: 0.009
-
Riley E, Trotter S, Dayer L, Teigen A, Nagel C, Stickley K, LaBorde P, Richardson L, McFerguson R, Ward N, Anders M. Interprofessional Naloxone Student Training to Manage Suspected Opioid Overdose. Clin Nurse Spec. 2023 Jan-Feb 01; 37(1):26-35.
Score: 0.009
-
Creighton EW, Dayer L, King D, Vural E, Sunde J, Moreno MA, Stack BC. Remote smart pill cap monitoring of post-surgical pain management in thyroid and parathyroid surgery. Am J Surg. 2023 06; 225(6):988-993.
Score: 0.009
-
Lakkad M, Martin B, Li C, Harrington S, Dayer L, Painter JT. Healthcare costs and utilization associated with pain among breast cancer survivors: a propensity score matched cohort study using SEER-Medicare data. J Cancer Surviv. 2023 08; 17(4):917-950.
Score: 0.009
-
Acharya M, Hayes CJ, Li C, Painter JT, Dayer L, Martin BC. Development of a potential opioid misuse measure from administrative dispensing data and contrasting opioid misuse among individuals on long-term tramadol, long-term short-acting hydrocodone or long-term short-acting oxycodone therapy in Arkansas. Curr Med Res Opin. 2022 11; 38(11):1947-1957.
Score: 0.009
-
Callaway K, Lakkad M, Painter JT, Dayer L, Oswalt AK. The Impact of Continuous Infusion Compared to Intravenous Bolus Administration of Pantoprazole on Length of Intensive Care Unit Stay in Critically Ill Patients. J Pharm Pract. 2023 Apr; 36(2):276-280.
Score: 0.008
-
Dragic L, Webb T, Chandler M, Harrington SB, McDade E, Dayer L, Painter JT. Comparing Effectiveness of Gabapentin and Pregabalin in Treatment of Neuropathic Pain: A Retrospective Cohort of Palliative Care Outpatients. J Pain Palliat Care Pharmacother. 2020 Dec; 34(4):192-196.
Score: 0.008
-
Pritchard ER, Dayer L, Belz J, Forseth B, Harrington SE, Painter JT. Effect of cannabis on opioid use in patients with cancer receiving palliative care. J Am Pharm Assoc (2003). 2020 Jan - Feb; 60(1):244-247.
Score: 0.007
-
Heldenbrand SD, Dayer LE, Martin BC, O'Brien C, Choi AN, Gubbins PO, Hawthorne J, Ramey M, Willis K, Flowers SK. APPE Evaluations are Positively Associated with MMI, Pre-pharmacy GPA and Pharmacy GPA. Am J Pharm Educ. 2018 09; 82(7):6326.
Score: 0.007
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|